CN109053749A - 一种普拉洛芬衍生物及其制备方法和用途 - Google Patents
一种普拉洛芬衍生物及其制备方法和用途 Download PDFInfo
- Publication number
- CN109053749A CN109053749A CN201810856849.7A CN201810856849A CN109053749A CN 109053749 A CN109053749 A CN 109053749A CN 201810856849 A CN201810856849 A CN 201810856849A CN 109053749 A CN109053749 A CN 109053749A
- Authority
- CN
- China
- Prior art keywords
- pranoprofen
- derivative
- eye
- preparation
- inflammation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/023—Preparation; Separation; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
化合物 | 在水中溶解度(mg/ml) | 化合物 | 在水中溶解度(mg/ml) |
I-1-1 | 39 | I-2-2 | 36 |
I-3-2 | 41 | RS-普拉洛芬(S1) | 0.05 |
化合物 | IC50(μM) | 化合物 | IC50(μM) |
RS-普拉洛芬(S1) | 5.4 | I-1-1 | 4.8 |
I-2-1 | 1.5 | I-2-2 | 1.1 |
I-3-1 | 9.7 | I-3-2 | 8.3 |
Claims (16)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810856849.7A CN109053749B (zh) | 2018-07-31 | 2018-07-31 | 一种普拉洛芬衍生物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810856849.7A CN109053749B (zh) | 2018-07-31 | 2018-07-31 | 一种普拉洛芬衍生物及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109053749A true CN109053749A (zh) | 2018-12-21 |
CN109053749B CN109053749B (zh) | 2021-04-30 |
Family
ID=64831812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810856849.7A Active CN109053749B (zh) | 2018-07-31 | 2018-07-31 | 一种普拉洛芬衍生物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109053749B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115521320A (zh) * | 2021-06-25 | 2022-12-27 | 沈阳兴齐眼药股份有限公司 | 一种制备普拉洛芬的方法 |
CN115677733A (zh) * | 2022-12-20 | 2023-02-03 | 济南宣正药业有限公司 | 一种用于普拉洛芬质量研究的化合物及其制备方法和应用 |
CN115959960A (zh) * | 2020-12-07 | 2023-04-14 | 南京知和医药科技有限公司 | 一种s-(+)-普拉洛芬衍生物及其制备方法、药物组合物和用途 |
WO2023122859A1 (zh) * | 2021-12-27 | 2023-07-06 | 南京知和医药科技有限公司 | 一种s-(+)-普拉洛芬衍生物及其制备方法、药物组合物和用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02289516A (ja) * | 1989-02-28 | 1990-11-29 | Asahi Chem Ind Co Ltd | (+)―プラノプロフェンを含有する医薬組成物 |
-
2018
- 2018-07-31 CN CN201810856849.7A patent/CN109053749B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02289516A (ja) * | 1989-02-28 | 1990-11-29 | Asahi Chem Ind Co Ltd | (+)―プラノプロフェンを含有する医薬組成物 |
Non-Patent Citations (6)
Title |
---|
JINJING ZHANG,等: "Evaluation of vancomycin-based synergistic system with amino acid ester chiral ionic liquids as additives for enantioseparation of non-steroidal anti-inflamatory drugs by capillary electrophoresis", 《TALANTA》 * |
KEWEN TANG,等: "Experimental and Modeling Studies on the Enantioselective Extraction of Hydrophobic Pranoprofen Enantiomers with Hydrophilic β-Cyclodextrin as Selectors", 《JOURNAL OF CHEMICAL & ENGINEERING DATA》 * |
NAOBUR0I OI,等: "Direct separation of carboxylic acid enantiomers by highperformance liquid chromatography with amide and urea derivatives bonded to silica gel as chiral stationary phases", 《JOURNAL OF CHROMATOGRAPHY A》 * |
TADAYUKI NOMURA,等: "Stereoselective Disposition of Pranoprofen, a Nonsteroidal Antiinflammatory Drug, in Rabbits", 《BIOL. PHARM. BULL》 * |
孙涛: "《家庭常用药物合理使用指南》", 31 October 2016, 吉林科学技术出版社 * |
尤启东,等: "《化学药物制备的工业化技术》", 31 March 2007, 化学工业出版社 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115959960A (zh) * | 2020-12-07 | 2023-04-14 | 南京知和医药科技有限公司 | 一种s-(+)-普拉洛芬衍生物及其制备方法、药物组合物和用途 |
CN115521320A (zh) * | 2021-06-25 | 2022-12-27 | 沈阳兴齐眼药股份有限公司 | 一种制备普拉洛芬的方法 |
CN115521320B (zh) * | 2021-06-25 | 2023-09-05 | 沈阳兴齐眼药股份有限公司 | 一种制备普拉洛芬的方法 |
WO2023122859A1 (zh) * | 2021-12-27 | 2023-07-06 | 南京知和医药科技有限公司 | 一种s-(+)-普拉洛芬衍生物及其制备方法、药物组合物和用途 |
CN115677733A (zh) * | 2022-12-20 | 2023-02-03 | 济南宣正药业有限公司 | 一种用于普拉洛芬质量研究的化合物及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN109053749B (zh) | 2021-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109053749A (zh) | 一种普拉洛芬衍生物及其制备方法和用途 | |
DE69816280T2 (de) | Inhibitoren des impdh-enzyms | |
CA2968061C (en) | Prodrugs of phenolic trpv1 agonists | |
EP1935892B1 (en) | Glycyrrhetinic acid-30-amide derivatives and the uses thereof | |
EP3012255B1 (en) | Stable crystal form of tipiracil hydrochloride and crystallization method for the same | |
CN1646538A (zh) | 托吡酯盐及其组合物、制备方法和应用 | |
JP6026400B2 (ja) | (1s,2s,3s,4r)−3−[(1s)−1−アセチルアミノ−2−エチル−ブチル]−4−グアニジノ−2−ヒドロキシ−シクロペンチル−1−カルボン酸水和物の製造方法 | |
CN103917536A (zh) | 1-吡唑基-3-(4-((2-(苯氨基嘧啶-4-基)氧基)萘-1-基)用作p38 MAP激酶抑制剂 | |
CN104684901A (zh) | 胱硫醚-γ-裂合酶(CSE)抑制剂 | |
CN110475550A (zh) | Crac通道抑制剂组合物 | |
CN105524033A (zh) | 达格列净的富马酸共晶体、其制备方法及药物组合物 | |
CN104557588A (zh) | 咖啡酸和阿魏酸的同二聚体,其制备方法及其药物组合物 | |
CN106715421A (zh) | 用于治疗hiv相关病症的方法和组合物 | |
RU2372336C2 (ru) | Соль, образованная из амина и производного карбостирила | |
CN105566314B (zh) | 一种盐酸替扎尼定化合物 | |
DE60005517T2 (de) | Kaliumkanal-blockierende mittel | |
JPH0240368A (ja) | 新規パラバン酸誘導体及び該化合物を有効成分として含有する医薬組成物 | |
HUE027711T2 (en) | An aqueous formulation of improved stability of (E) -4-carboxystyril-4-chlorobenzylsulfone | |
CN104854082A (zh) | 3,5,n-三羟基烷酰胺及其衍生物、及其制造方法与用途 | |
US10093610B2 (en) | Crystalline inhibitor of 4-hydroxyphenylpyruvate dioxygenase | |
DE69627209T2 (de) | Lyophilisiertes thioxanthenon-antitumormedikament | |
CN105693793B (zh) | 一种利巴韦林化合物及其药物组合物 | |
CN101142214B (zh) | 奥卡哌酮盐及含奥卡哌酮盐的药用组合物 | |
CN116102486B (zh) | 甲磺酸阿比多尔晶型ⅳ及其制备方法和用途 | |
JP2017031083A (ja) | 抗アレルギー剤及びメディエーター遊離阻害剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190215 Address after: 610000 No. 80 Peifeng Road, Qingyang District, Chengdu City, Sichuan Province, 13 Building 8, Unit 5, No. 8 Applicant after: Xu Qing Address before: 610000 No. 97 Ziwei East Road, Chengdu High-tech Zone, Sichuan Province Applicant before: CHENGDU YISHAN BIOTECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230118 Address after: No. 907, Floor 9, Building 12, No. 88, Keyuan South Road, High-tech Zone, Chengdu, Sichuan, 610000 Patentee after: CHENGDU BENUO KECHENG BIOTECHNOLOGY Co.,Ltd. Address before: 610000 No. 80 Peifeng Road, Qingyang District, Chengdu City, Sichuan Province, 13 Building 8, Unit 5, No. 8 Patentee before: Xu Qing |